PubRank

Andreas Hartmann

Author PubWeight™ 90.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Self-terminating diffraction gates femtosecond X-ray nanocrystallography measurements. Nat Photonics 2012 3.68
2 Lipidic phase membrane protein serial femtosecond crystallography. Nat Methods 2012 2.76
3 In vivo protein crystallization opens new routes in structural biology. Nat Methods 2012 2.69
4 Time-resolved protein nanocrystallography using an X-ray free-electron laser. Opt Express 2012 2.38
5 Radiation damage in protein serial femtosecond crystallography using an x-ray free-electron laser. Phys Rev B Condens Matter Mater Phys 2011 2.05
6 Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke 2006 2.05
7 Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J 2011 1.75
8 Functional immaturity of cortico-basal ganglia networks in Gilles de la Tourette syndrome. Brain 2012 1.69
9 Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction). JACC Cardiovasc Interv 2011 1.68
10 Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest 2010 1.64
11 Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease. Exp Neurol 2005 1.58
12 Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup. Mutat Res 2006 1.51
13 Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy. Curr Opin Neurol 2006 1.50
14 Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction. Eur Heart J 2005 1.44
15 Neuroinflammatory processes in Parkinson's disease. Parkinsonism Relat Disord 2005 1.39
16 European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry 2011 1.33
17 Disconnecting force from money: effects of basal ganglia damage on incentive motivation. Brain 2008 1.31
18 European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur Child Adolesc Psychiatry 2011 1.31
19 Unsupervised classification of single-particle X-ray diffraction snapshots by spectral clustering. Opt Express 2011 1.27
20 Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults. Nat Neurosci 2011 1.24
21 The ARUBA trial: current status, future hopes. Stroke 2010 1.22
22 Oxidative stress induces senescence in chondrocytes. J Orthop Res 2011 1.20
23 Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice. Exp Neurol 2007 1.20
24 The in vivo comet assay: use and status in genotoxicity testing. Mutagenesis 2005 1.18
25 The comet assay: a sensitive genotoxicity test for the detection of DNA damage and repair. Methods Mol Biol 2006 1.12
26 Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J Neurosci 2007 1.10
27 Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome. Brain 2010 1.09
28 Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes. Proc Natl Acad Sci U S A 2009 1.08
29 Femtosecond free-electron laser x-ray diffraction data sets for algorithm development. Opt Express 2012 1.07
30 Toward unsupervised single-shot diffractive imaging of heterogeneous particles using X-ray free-electron lasers. Opt Express 2013 1.04
31 The comet assay as an indicator test for germ cell genotoxicity. Mutat Res 2008 1.00
32 Role of TNF-alpha receptors in mice intoxicated with the parkinsonian toxin MPTP. Exp Neurol 2002 0.99
33 Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both? PLoS One 2010 0.98
34 Sensing the wavefront of x-ray free-electron lasers using aerosol spheres. Opt Express 2013 0.97
35 Multimodal early rehabilitation and predictors of outcome in survivors of severe traumatic brain injury. J Trauma 2008 0.96
36 High throughput Comet assay using 96-well plates. Mutagenesis 2002 0.96
37 Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model. PLoS One 2013 0.96
38 Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Sci Rep 2013 0.94
39 Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection. Toxicol Sci 2007 0.92
40 Gene expression profiles derived from single cells in human postmortem brain. Brain Res Brain Res Protoc 2004 0.91
41 Towards the creation of an international toxicology information centre. Toxicology 2005 0.91
42 Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid. J Neurochem 2008 0.91
43 Cerebrovascular reactivity in major depression: a pilot study. Psychosom Med 2004 0.90
44 Orthostatic tremor in monozygotic twins. Neurology 2006 0.90
45 The comet assay: a sensitive genotoxicity test for the detection of DNA damage. Methods Mol Biol 2005 0.89
46 Bystander effects in radiation-induced genomic instability. Mutat Res 2002 0.89
47 Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism: role of granulocyte macrophage colony-stimulating factor. J Neurochem 2005 0.88
48 Genetic association signal near NTN4 in Tourette syndrome. Ann Neurol 2014 0.87
49 Increased prevalence of microangiopathic brain lesions among siblings of patients with lacunar stroke. A prospective multicenter study. Eur Neurol 2007 0.86
50 Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats. Brain Res 2005 0.85
51 Aripiprazole: a treatment for severe coprolalia in "refractory" Gilles de la Tourette syndrome. Mov Disord 2008 0.85
52 Quality of life in adults with Gilles de la Tourette Syndrome. BMC Psychiatry 2012 0.85
53 Prolonged generalized dystonia after chronic cerebellar application of kainic acid. Brain Res 2012 0.84
54 Dopamine-dependent reinforcement of motor skill learning: evidence from Gilles de la Tourette syndrome. Brain 2011 0.84
55 Joint Morphometry of Fiber Tracts and Gray Matter Structures Using Double Diffeomorphisms. Inf Process Med Imaging 2015 0.84
56 Human health risk assessment of carbamazepine in surface waters of North America and Europe. Regul Toxicol Pharmacol 2009 0.84
57 Role of activity-dependent mechanisms in the control of dopaminergic neuron survival. J Neurochem 2007 0.83
58 Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects. Neurobiol Dis 2006 0.82
59 A toxicity identification evaluation approach to studying estrogenic substances in hog manure and agricultural runoff. Environ Toxicol Chem 2003 0.82
60 Effects of perfusion and dynamic loading on human neocartilage formation in alginate hydrogels. Tissue Eng Part A 2012 0.82
61 Reinforcement learning and Gilles de la Tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments. Arch Gen Psychiatry 2011 0.82
62 Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease. J Neuroinflammation 2014 0.82
63 Gaucher disease and monoclonal gammopathy: a report of 17 cases and impact of therapy. Blood Cells Mol Dis 2009 0.81
64 Altered structure of cortical sulci in gilles de la Tourette syndrome: Further support for abnormal brain development. Mov Disord 2015 0.81
65 The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial. Ann Neurol 2011 0.81
66 Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease? Parkinsonism Relat Disord 2008 0.81
67 Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy. Brain 2010 0.80
68 Assessment of DNA damage in coal open-cast mining workers using the cytokinesis-blocked micronucleus test and the comet assay. Sci Total Environ 2011 0.79
69 Genotoxicity assessment of the antiepileptic drug AMP397, an Ames-positive aromatic nitro compound. Mutat Res 2002 0.79
70 CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease. Neurodegener Dis 2012 0.78
71 Probenecid potentiates MPTP/MPP+ toxicity by interference with cellular energy metabolism. J Neurochem 2013 0.78
72 A strategy to reduce the numbers of fish used in acute ecotoxicity testing of pharmaceuticals. Environ Toxicol Chem 2003 0.78
73 Parsimonious Approximation of Streamline Trajectories in White Matter Fiber Bundles. IEEE Trans Med Imaging 2016 0.77
74 Genotoxic effects in wild rodents (Rattus rattus and Mus musculus) in an open coal mining area. Mutat Res 2007 0.77
75 Distribution of intraperitoneally injected diclofenac in brown trout (Salmo trutta f. fario). Ecotoxicol Environ Saf 2008 0.77
76 ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention. Am J Cardiol 2006 0.77
77 Diclofenac: New data on chronic toxicity and bioconcentration in fish. Environ Toxicol Chem 2013 0.77
78 Motor tic of the neck: a probable cause of stroke in a child with Gilles de la Tourette syndrome. Mov Disord 2011 0.76
79 Altered cholinergic neurotransmission in Tourette syndrome. Mov Disord 2015 0.75
80 Increasing histamine neurotransmission in Gilles de la Tourette syndrome. J Neurol 2011 0.75
81 Granulocyte colony-stimulating factor is not protective against selective dopaminergic cell death in vitro. Neurosci Lett 2005 0.75
82 Correction: Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial. PLoS One 2016 0.75
83 Ultramicrosensors based on transition metal hexacyanoferrates for scanning electrochemical microscopy. Beilstein J Nanotechnol 2013 0.75
84 A novel transosseous button technique for rotator cuff repair. Arthroscopy 2008 0.75
85 Functional impairments for outcomes in a randomized trial of unruptured brain AVMs. Neurology 2017 0.75
86 A prototype representation to approximate white matter bundles with weighted currents. Med Image Comput Comput Assist Interv 2014 0.75
87 Relationship between selected overdrive parameters and the therapeutic outcome and tolerance of atrial overdrive pacing. Pacing Clin Electrophysiol 2003 0.75
88 The COGNITION study rationale and design: influence of closed loop stimulation on cognitive performance in pacemaker patients. Pacing Clin Electrophysiol 2008 0.75
89 Rate-adaptive pacing using intracardiac impedance shows no evidence for positive feedback during dobutamine stress test. Europace 2002 0.75
90 [Current aspects of electrical cardioversion in patients with persistent atrial fibrillation]. Med Klin (Munich) 2004 0.75